Syndax Pharmaceuticals (SNDX) Operating Expenses (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Operating Expenses of $99.1 million for Q1 2026, down 4.56% year-over-year from $103.8 million in Q1 2025, and down 24.54% quarter-over-quarter from $131.3 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Operating Expenses (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Operating Expenses history runs 12 years deep, the most recent figure standing at $99.1 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 4.56% year-over-year to $99.1 million; the TTM figure through Mar 2026 stood at $441.0 million (up 13.75% YoY), while the FY2025 annual figure was $445.4 million, up 22.59% from the prior year.
- Operating Expenses for Q1 2026 stood at $99.1 million, down from $131.3 million in the prior quarter.
- The five-year high for Operating Expenses was $131.3 million in Q4 2025, with the low at $35.1 million in Q3 2022.
- The 5-year median for Operating Expenses is $77.9 million (2023), against an average of $75.9 million.
- The sharpest annual moves came in 2023 and 2026: Operating Expenses surged 85.34% in 2023, then dropped 4.56% in 2026.
- Syndax Pharmaceuticals' Operating Expenses stood at $42.0 million in 2022, then soared by 85.34% to $77.9 million in 2023, then soared by 33.55% to $104.0 million in 2024, then gained by 26.17% to $131.3 million in 2025, then slipped by 24.54% to $99.1 million in 2026.
- Business Quant data shows SNDX's Operating Expenses at $99.1 million in Q1 2026, $131.3 million in Q4 2025, and $103.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | 112.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.78 Mn |
| Mar 31, 2026 | 99.07 Mn |
| Dec 31, 2025 | 131.28 Mn |
| Sep 30, 2025 | 103.30 Mn |
| Jun 30, 2025 | 107.31 Mn |
| Mar 31, 2025 | 103.80 Mn |
| Dec 31, 2024 | 104.05 Mn |
| Sep 30, 2024 | 102.08 Mn |
| Jun 30, 2024 | 77.72 Mn |
| Mar 31, 2024 | 79.51 Mn |
| Dec 31, 2023 | 77.91 Mn |
| Sep 30, 2023 | 56.36 Mn |
| Jun 30, 2023 | 49.68 Mn |
| Mar 31, 2023 | 46.02 Mn |
| Dec 31, 2022 | 42.03 Mn |
| Sep 30, 2022 | 35.14 Mn |
| Jun 30, 2022 | 37.72 Mn |
| Mar 31, 2022 | 36.86 Mn |
| Dec 31, 2021 | 30.83 Mn |
| Sep 30, 2021 | 32.41 Mn |